Hope on the Horizon for Alzheimer's Patients and Caregivers
Topic: Alzheimer's Disease
Author: USF Health's Byrd Alzheimer's Institute
Published: 2010/11/21
Contents: Summary - Introduction - Main Item - Related Topics
Synopsis: New medicines in the pipeline for Alzheimers disease and other dementias.
Introduction
USF Health Byrd Alzheimer's Institute researchers to discuss latest advances, including new medications in the pipeline.Main Item
America's biopharmaceutical research companies highlighted the 98 new medicines in the pipeline for Alzheimer's disease and other dementias, either in clinical trials or awaiting FDA review. Researchers, patients, caregivers, advocacy groups and students gathered at the University of South Florida Health Byrd Alzheimer's Institute to discuss the newest advances in Alzheimer's research and to take a look into the future of this debilitating disease. Currently, there are only five medicines approved for Alzheimer's. While these medicines temporarily reduce the symptoms for some patients, biopharmaceutical companies are working to develop new medicines to prevent, delay or cure Alzheimer's.
"The American biomedical enterprise is making progress in the treatment of Alzheimer's disease," said Dr. David Morgan, CEO of the Institute. "The richness of the public-private partnerships between universities, research institutes, biotechnology companies and major biopharmaceutical companies is the envy of the world."
Research facilities, like the USF Health Byrd Alzheimer's Institute are making breakthroughs with this devastating disease. These advances have expedited the understanding of the causes of Alzheimer's. New imaging technologies, such as positron emission tomography (PET) scans, provide scientists a glimpse into the brain, overcoming the prior inability to access brain tissue. PET scans and other biomarkers are revealing the earliest signs of Alzheimer's even before symptoms appear.
The Honorable Johnnie Byrd, Jr., founder and board member of the Institute highlights the importance of the research conducted at the Institute and the economic impact of the disease.
"As of 2010, the estimated total cost of caring for Alzheimer's patients is $172 billion, including Medicare, private insurance, out-of-pocket costs and uncompensated care. Families drain their life savings and lose their homes paying for care," stated Mr. Byrd.
Today, more than five million Americans are living with dementia, and one in 40 Floridians has dementia. Alzheimer's disease, the most common form of dementia, has become the seventh leading cause of death in America, and is the only cause of death that is moving up in the rankings. Alzheimer's is a disease of aging, with typical onset in the late 70s and 80s. The number of Americans living with Alzheimer's is expected to increase as the baby boomers age, and people live longer due to advances in treating infections, heart disease and cancer. It is estimated that 10 million baby boomers will die of this disease without a treatment that slows or prevents Alzheimer's.
For more information on USF Health's Byrd Alzheimer's Institute, visit health.usf.edu/nocms/byrd
Explore Related Topics
1 - Alzheimer's Unseen: Disease Present Without Symptoms - Gene-expression profiling of individuals resilient to Alzheimer's disease reveals higher expression of genes related to metallothionein and mitochondrial processes and no changes in the unfolded protein response.
2 - Rusting Iron in the Brain May Be Cause of Alzheimer's Disease - A newly found link between Alzheimer's Disease and iron could lead to new medical interventions.
3 - OCTA Eye Scan May Detect Sign of Early Alzheimer's Disease - Results from two studies show that a new, non-invasive imaging device can see signs of Alzheimer's disease in a matter of seconds.
4 - Music Activates Regions of the Brain Spared By Alzheimer's Disease - Researchers at the University of Utah Health looking to the salience network of the brain to develop music based treatments to help alleviate anxiety in patients with dementia.
5 - Importance of Family History for Onset of Alzheimer's Disease - Study reveals the closer a person gets to the age at which their parent exhibited the first signs of Alzheimer's disease, the more likely they are to have amyloid plaques, the cause of the cognitive decline.
Page Information, Citing and Disclaimer
Disabled World is a comprehensive online resource that provides information and news related to disabilities, assistive technologies, and accessibility issues. Founded in 2004 our website covers a wide range of topics, including disability rights, healthcare, education, employment, and independent living, with the goal of supporting the disability community and their families.
Cite This Page (APA): USF Health's Byrd Alzheimer's Institute. (2010, November 21). Hope on the Horizon for Alzheimer's Patients and Caregivers. Disabled World. Retrieved October 13, 2024 from www.disabled-world.com/health/aging/alzheimers/future-medicine.php
Permalink: <a href="https://www.disabled-world.com/health/aging/alzheimers/future-medicine.php">Hope on the Horizon for Alzheimer's Patients and Caregivers</a>: New medicines in the pipeline for Alzheimers disease and other dementias.
Disabled World provides general information only. Materials presented are never meant to substitute for qualified medical care. Any 3rd party offering or advertising does not constitute an endorsement.